These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 18929321)

  • 1. Delivering effective anticoagulation in atrial fibrillation: we can do better!
    Verma S
    Heart Rhythm; 2008 Oct; 5(10):1373-4. PubMed ID: 18929321
    [No Abstract]   [Full Text] [Related]  

  • 2. Potentially preventable strokes in high-risk patients with atrial fibrillation who are not adequately anticoagulated.
    Gladstone DJ; Bui E; Fang J; Laupacis A; Lindsay MP; Tu JV; Silver FL; Kapral MK
    Stroke; 2009 Jan; 40(1):235-40. PubMed ID: 18757287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation.
    Hylek EM; Go AS; Chang Y; Jensvold NG; Henault LE; Selby JV; Singer DE
    N Engl J Med; 2003 Sep; 349(11):1019-26. PubMed ID: 12968085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The quality of anticoagulation on functional outcome and mortality for TIA/stroke in atrial fibrillation patients.
    Poli D; Antonucci E; Marcucci R; Mannini L; Falciani M; Abbate R; Gensini GF; Prisco D
    Int J Cardiol; 2009 Feb; 132(1):109-13. PubMed ID: 18180057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patients with atrial fibrillation often receive improper levels of warfarin.
    Mitka M
    JAMA; 2008 Oct; 300(14):1640. PubMed ID: 18840828
    [No Abstract]   [Full Text] [Related]  

  • 6. Efficacy and safety of apixaban compared with warfarin at different levels of predicted international normalized ratio control for stroke prevention in atrial fibrillation.
    Wallentin L; Lopes RD; Hanna M; Thomas L; Hellkamp A; Nepal S; Hylek EM; Al-Khatib SM; Alexander JH; Alings M; Amerena J; Ansell J; Aylward P; Bartunek J; Commerford P; De Caterina R; Erol C; Harjola VP; Held C; Horowitz JD; Huber K; Husted S; Keltai M; Lanas F; Lisheng L; McMurray JJ; Oh BH; Rosenqvist M; Ruzyllo W; Steg PG; Vinereanu D; Xavier D; Granger CB;
    Circulation; 2013 Jun; 127(22):2166-76. PubMed ID: 23640971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Warfarin for stroke prevention in atrial fibrillation: time to switch?
    Ahmad Y; Lip GY
    Int J Clin Pract; 2013 Jul; 67(7):603-5. PubMed ID: 23758442
    [No Abstract]   [Full Text] [Related]  

  • 8. Outcomes of discontinuing rivaroxaban compared with warfarin in patients with nonvalvular atrial fibrillation: analysis from the ROCKET AF trial (Rivaroxaban Once-Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation).
    Patel MR; Hellkamp AS; Lokhnygina Y; Piccini JP; Zhang Z; Mohanty S; Singer DE; Hacke W; Breithardt G; Halperin JL; Hankey GJ; Becker RC; Nessel CC; Berkowitz SD; Califf RM; Fox KA; Mahaffey KW
    J Am Coll Cardiol; 2013 Feb; 61(6):651-8. PubMed ID: 23391196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protocol for Birmingham Atrial Fibrillation Treatment of the Aged study (BAFTA): a randomised controlled trial of warfarin versus aspirin for stroke prevention in the management of atrial fibrillation in an elderly primary care population [ISRCTN89345269].
    Mant JW; Richards SH; Hobbs FD; Fitzmaurice D; Lip GY; Murray E; Banting M; Fletcher K; Rahman J; Allan T; Raftery J; Bryan S;
    BMC Cardiovasc Disord; 2003 Aug; 3():9. PubMed ID: 12939169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticoagulation intensity for elderly atrial fibrillation patients: should we use a conventional INR target (2.0 to 3.0) or a lower range?
    Lane DA; Lip GY
    Thromb Haemost; 2010 Feb; 103(2):254-6. PubMed ID: 20076858
    [No Abstract]   [Full Text] [Related]  

  • 11. Oral anticoagulant therapy for patients with atrial fibrillation--an update.
    Hylek EM
    Thromb Res; 2008; 123 Suppl 1():S46-9. PubMed ID: 18809205
    [No Abstract]   [Full Text] [Related]  

  • 12. Net clinical benefit of warfarin in patients with atrial fibrillation: a report from the Swedish atrial fibrillation cohort study.
    Friberg L; Rosenqvist M; Lip GY
    Circulation; 2012 May; 125(19):2298-307. PubMed ID: 22514252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cochrane corner: vitamin K for improved anticoagulation control in patients receiving warfarin.
    Mahtani KR; Nunan D; Heneghan C
    Heart; 2015 Nov; 101(21):1689-90. PubMed ID: 26135804
    [No Abstract]   [Full Text] [Related]  

  • 14. Lower-dose warfarin delays renal progression and prolongs patient survival in patients with stage 3 - 5 chronic kidney disease and nonvalvular atrial fibrillation: a 12-year follow-up study.
    Chiu PF; Huang CH; Liou HH; Wu CL; Chang C; Chang CC; Chang HR
    Int J Clin Pharmacol Ther; 2014 Jun; 52(6):504-8. PubMed ID: 24755133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sustainability and impact of warfarin compliance for atrial fibrillation.
    Kuo S; Burrill J
    Med Health R I; 2007 Dec; 90(12):378-80. PubMed ID: 18314828
    [No Abstract]   [Full Text] [Related]  

  • 16. Relation of effective anticoagulation in patients with atrial fibrillation to stroke severity and survival (from the National Acute Stroke Israeli Survey [NASIS]).
    Schwammenthal Y; Bornstein N; Schwammenthal E; Schwartz R; Goldbourt U; Tsabari R; Koton S; Grossman E; Tanne D
    Am J Cardiol; 2010 Feb; 105(3):411-6. PubMed ID: 20102959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of oral anticoagulation among stroke patients with atrial fibrillation in China: the ChinaQUEST (Quality evaluation of stroke care and treatment) registry study.
    Gao Q; Fu X; Wei JW; Chen X; Huang Y; Wang J; Anderson CS; Wong KS;
    Int J Stroke; 2013 Apr; 8(3):150-4. PubMed ID: 22168348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of Warfarin at Discharge Among Acute Ischemic Stroke Patients With Nonvalvular Atrial Fibrillation in China.
    Yang X; Li Z; Zhao X; Wang C; Liu L; Wang C; Pan Y; Li H; Wang D; Hart RG; Wang Y; Wang Y;
    Stroke; 2016 Feb; 47(2):464-70. PubMed ID: 26696643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dabigatran versus warfarin in patients with atrial fibrillation.
    Poller L; Jespersen J; Ibrahim S
    N Engl J Med; 2009 Dec; 361(27):2673-4; author reply 2674-5. PubMed ID: 20050386
    [No Abstract]   [Full Text] [Related]  

  • 20. Anticoagulation: a pathway to clinical effectiveness.
    Barnes GD; Froehlich JB
    Am J Med; 2009 Feb; 122(2):126-8. PubMed ID: 19185085
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.